Tao Feng
Zai Lab, China
Biography
Dr. Feng is currently Senior Director of CMC at Zailab, responsible for drug product development and manufacturing to support Zailab’s clinical and commercial programs. Dr. Feng has more than 12 years’ experience in new drug research and development including preclinical candidate characterization, preformulation, formulation development, and GMP manufacturing. Prior to joining Zai, Dr. Feng was Director of pharmaceutical development at WuXi Apptec, responsible for formulation development and GMP manufacturing of many new drug programs. Prior to WuXi Apptec, Dr. Feng worked at Schering-Plough in New Jersey US, where he led the preclinical candidate characterization activities to support multiple new drug discovery programs to progress into development phase. Dr. Feng received his PhD from Purdue University.
Abstract
Abstract : Effective utilization of preformulation studies to guide drug product development